Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee.
Vossler DG, Bainbridge JL, Boggs JG, Novotny EJ, Loddenkemper T, Faught E, Amengual-Gual M, Fischer SN, Gloss DS, Olson DM, Towne AR, Naritoku D, Welty TE. Vossler DG, et al. Among authors: faught e. Epilepsy Curr. 2020 Sep;20(5):245-264. doi: 10.1177/1535759720928269. Epub 2020 Aug 21. Epilepsy Curr. 2020. PMID: 32822230 Free PMC article.
Step therapy is not appropriate for antiepileptic drugs.
Welty TE, Faught E, Privitera MD. Welty TE, et al. Among authors: faught e. J Manag Care Pharm. 2006 Apr;12(3):269-70; author reply 270-1. doi: 10.18553/jmcp.2006.12.3.269. J Manag Care Pharm. 2006. PMID: 16623614 Free PMC article.
Tiagabine in clinical practice: effects on seizure control and behavior.
Vossler DG, Morris GL 3rd, Harden CL, Montouris G, Faught E, Kanner AM, Fix A, French JA; Postmarketing Antiepileptic Drug Survey (PADS) group study investigators. Vossler DG, et al. Among authors: faught e. Epilepsy Behav. 2013 Aug;28(2):211-6. doi: 10.1016/j.yebeh.2013.05.006. Epub 2013 Jun 13. Epilepsy Behav. 2013. PMID: 23770680 Clinical Trial.
Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Llanas Park E, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J. Kanner AM, et al. Among authors: faught e. Neurology. 2018 Jul 10;91(2):74-81. doi: 10.1212/WNL.0000000000005755. Epub 2018 Jun 13. Neurology. 2018. PMID: 29898971
Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Llanas Park E, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J. Kanner AM, et al. Among authors: faught e. Neurology. 2018 Jul 10;91(2):82-90. doi: 10.1212/WNL.0000000000005756. Epub 2018 Jun 13. Neurology. 2018. PMID: 29898974
Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Park EL, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J. Kanner AM, et al. Among authors: faught e. Epilepsy Curr. 2018 Jul-Aug;18(4):260-268. doi: 10.5698/1535-7597.18.4.260. Epilepsy Curr. 2018. PMID: 30254527 Free PMC article.
269 results